Use of sulfite derivatives in French pharmaceutical products in 2022 (notice n° 179446)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01403cam a2200193 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112041230.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Morel, Daphné |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Use of sulfite derivatives in French pharmaceutical products in 2022 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2023.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 60 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Sulfites are among the 37 excipients with a possible known effect listed by the French National Agency for Medicines and Health Products Safety (ANSM) that can be found in French pharmaceutical registered drugs. They can trigger severe hypersensitivity reactions and bronchospasm in intolerant patients. General guidelines for sensitive patients merely advise “avoiding wines and products with high sulfite content,” without specifying the risk–if any–of prescribing and dispensing medications containing sulfites. In this article, we discuss the use of sulfites in French registered drugs: Who are the patients at risk of intolerance reactions? Which drugs contain sulfites? In what quantity? And should their administration be monitored in sensitive patients? |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Verlingue, Loïc |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tillement, Olivier |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Deutsch, Eric |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Journal de Pharmacie Clinique | 42 | 3 | 2023-07-01 | p. 109-118 | 0291-1981 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-journal-de-pharmacie-clinique-2023-3-page-109?lang=en">https://shs.cairn.info/journal-journal-de-pharmacie-clinique-2023-3-page-109?lang=en</a> |
Pas d'exemplaire disponible.
Réseaux sociaux